Respiratory Distress Syndrome in Late Preterm Infants: Understanding the Risks and Implications
*Corresponding Author: Mahbod Sadatinejad, Department of Pediatrics, Shahid Chamran University, Ahvaz, Iran, Email: sada_mahbob@gmail.comReceived Date: Sep 18, 2024 / Published Date: Feb 08, 2026
Citation: Sadatinejad M (2026) Respiratory Distress Syndrome in Late Preterm Infants: Understanding the Risks and Implications. Neonat Pediatr Med 12: 621DOI: 10.4172/2572-4983.1000621
Copyright: © 2026 Sadatinejad M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Respiratory Distress Syndrome (RDS) is a critical condition that primarily affects preterm infants due to insufficient surfactant production in the lungs. While commonly associated with extremely preterm births, RDS also significantly impacts late preterm infants (born between 34 and 36 weeks of gestation). This article examines the increased morbidity and mortality associated with RDS in late preterm infants, highlighting the adverse outcomes such as respiratory failure, prolonged hospitalization, and higher mortality rates. Key risk factors contributing to RDS in this population include maternal diabetes, hypertension, multiple gestations, and cesarean delivery. Effective management strategies, including antenatal corticosteroids, surfactant replacement therapy, and supportive care, are crucial for mitigating the risks and improving outcomes. Understanding and addressing these factors are essential for enhancing neonatal care and supporting the health and development of late preterm infants.

